New York State Common Retirement Fund’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.95M | Buy |
91,354
+6,000
| +7% | +$259K | 0.01% | 1162 |
|
2025
Q1 | $2.95M | Buy |
85,354
+33,178
| +64% | +$1.15M | ﹤0.01% | 1247 |
|
2024
Q4 | $1.43M | Buy |
52,176
+928
| +2% | +$25.5K | ﹤0.01% | 1530 |
|
2024
Q3 | $1.31M | Sell |
51,248
-7,168
| -12% | -$183K | ﹤0.01% | 1562 |
|
2024
Q2 | $1.48M | Sell |
58,416
-15,744
| -21% | -$399K | ﹤0.01% | 1585 |
|
2024
Q1 | $2.29M | Buy |
74,160
+5,863
| +9% | +$181K | ﹤0.01% | 1420 |
|
2023
Q4 | $2.76M | Buy |
68,297
+20,251
| +42% | +$817K | ﹤0.01% | 1334 |
|
2023
Q3 | $1.27M | Buy |
48,046
+4,197
| +10% | +$111K | ﹤0.01% | 1632 |
|
2023
Q2 | $754K | Sell |
43,849
-11,763
| -21% | -$202K | ﹤0.01% | 1906 |
|
2023
Q1 | $922K | Sell |
55,612
-16,674
| -23% | -$276K | ﹤0.01% | 1893 |
|
2022
Q4 | $551K | Sell |
72,286
-26
| -0% | -$198 | ﹤0.01% | 2268 |
|
2022
Q3 | $719K | Buy |
72,312
+97
| +0.1% | +$964 | ﹤0.01% | 2151 |
|
2022
Q2 | $656K | Sell |
72,215
-84
| -0.1% | -$763 | ﹤0.01% | 2225 |
|
2022
Q1 | $734K | Sell |
72,299
-109,348
| -60% | -$1.11M | ﹤0.01% | 2245 |
|
2021
Q4 | $3.03M | Buy |
181,647
+18,295
| +11% | +$305K | ﹤0.01% | 1552 |
|
2021
Q3 | $7.66M | Sell |
163,352
-132,727
| -45% | -$6.22M | 0.01% | 1126 |
|
2021
Q2 | $18M | Buy |
296,079
+15,834
| +6% | +$965K | 0.02% | 723 |
|
2021
Q1 | $17.3M | Buy |
280,245
+78,556
| +39% | +$4.84M | 0.02% | 706 |
|
2020
Q4 | $14.3M | Buy |
201,689
+122,433
| +154% | +$8.71M | 0.02% | 781 |
|
2020
Q3 | $2.97M | Hold |
79,256
| – | – | ﹤0.01% | 1371 |
|
2020
Q2 | $2.59M | Buy |
79,256
+22,456
| +40% | +$732K | ﹤0.01% | 1430 |
|
2020
Q1 | $1.65M | Buy |
56,800
+36,800
| +184% | +$1.07M | ﹤0.01% | 1498 |
|
2019
Q4 | $701K | Buy |
20,000
+2,300
| +13% | +$80.6K | ﹤0.01% | 2118 |
|
2019
Q3 | $380K | Buy |
+17,700
| New | +$380K | ﹤0.01% | 2467 |
|